Literature DB >> 15590193

Magnetic resonance assessment of prostate localization variability in intensity-modulated radiotherapy for prostate cancer.

Geert M Villeirs1, Gert O De Meerleer, Koenraad L Verstraete, Wilfried J De Neve.   

Abstract

PURPOSE: To measure prostate motion with magnetic resonance imaging (MRI) during a course of intensity-modulated radiotherapy. METHODS AND MATERIALS: Seven patients with prostate carcinoma were scanned supine on a 1.5-Tesla MRI system with weekly pretreatment and on-treatment HASTE T2-weighted images in 3 orthogonal planes. The bladder and rectal volumes and position of the prostatic midpoint (PMP) and margins relative to the bony pelvis were measured.
RESULTS: All pretreatment positions were at the mean position as computed from the on-treatment scans in each patient. The PMP variability (given as 1 SD) in the anterior-posterior (AP), superior-inferior (SI), and right-left (RL) directions was 2.6, 2.4, and 1.0 mm, respectively. The largest variabilities occurred at the posterior (3.2 mm), superior (2.6 mm), and inferior (2.6 mm) margins. A strong correlation was found between large rectal volume (>95th percentile) and anterior PMP displacement. A weak correlation was found between bladder volume and superior PMP displacement.
CONCLUSIONS: All pretreatment positions were representative of the subsequent on-treatment positions. A clinical target volume (CTV) expansion of 5.3 mm in any direction was sufficient to ascertain a 95% coverage of the CTV within the planning target volume (PTV), provided that a rectal suppository is administered to avoid rectal overdistension and that the patient has a comfortably filled bladder (<300 mL).

Entities:  

Mesh:

Year:  2004        PMID: 15590193     DOI: 10.1016/j.ijrobp.2004.07.711

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  Preliminary experience of a predictive model to define rectal volume and rectal dose during the treatment of prostate cancer.

Authors:  M D Falco; M D'Andrea; D Fedele; R Barbarino; M Benassi; E Giudice; E Hamoud; G Ingrosso; P Ladogana; F Santarelli; G Tortorelli; R Santoni
Journal:  Br J Radiol       Date:  2011-09       Impact factor: 3.039

2.  Variability in bladder volumes of full bladders in definitive radiotherapy for cases of localized prostate cancer.

Authors:  Naoki Nakamura; Naoto Shikama; Osamu Takahashi; Makiko Ito; Masatoshi Hashimoto; Masahiro Uematsu; Yukihiro Hama; Kenji Sekiguchi; Keiichi Nakagawa
Journal:  Strahlenther Onkol       Date:  2010-11-08       Impact factor: 3.621

3.  Evaluation of two-dimensional electronic portal imaging device using integrated images during volumetric modulated arc therapy for prostate cancer.

Authors:  Shoki Inui; Yoshihiro Ueda; Shunsuke Ono; Shingo Ohira; Masaru Isono; Yuya Nitta; Hikari Ueda; Masayoshi Miyazaki; Masahiko Koizumi; Teruki Teshima
Journal:  Rep Pract Oncol Radiother       Date:  2021-04-14

4.  A "rolling average" multiple adaptive planning method to compensate for target volume changes in image-guided radiotherapy of prostate cancer.

Authors:  Han Liu; Qiuwen Wu
Journal:  J Appl Clin Med Phys       Date:  2012-01-05       Impact factor: 2.102

5.  The effect of bowel preparation regime on interfraction rectal filling variation during image guided radiotherapy for prostate cancer.

Authors:  Ali Hosni; Tara Rosewall; Timothy Craig; Vickie Kong; Andrew Bayley; Alejandro Berlin; Robert Bristow; Charles Catton; Padraig Warde; Peter Chung
Journal:  Radiat Oncol       Date:  2017-03-09       Impact factor: 3.481

6.  Bladder volume reproducibility after water consumption in patients with prostate cancer undergoing radiotherapy: A systematic review and meta-analysis.

Authors:  Hsiao-Hsuan Chen; Pei-Tzu Lin; Liang-Tseng Kuo; Kun-Sheng Lin; Chiung-Chen Fang; Ching-Chi Chi
Journal:  Biomed J       Date:  2020-11-04       Impact factor: 7.892

7.  Three-dimensional MRI evaluation of the effect of bladder volume on prostate translocation and distortion.

Authors:  Ziga Snoj; Andrew B Gill; Leonardo Rundo; Nikita Sushentsev; Tristan Barrett
Journal:  Radiol Oncol       Date:  2020-01-14       Impact factor: 2.991

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.